Institutional investors back a $300 million flotation for inhaled pulmonary fibrosis therapies, signalling stronger risk appetite for clinical-stage biotech listings and sharpening...
The $2 trillion U.S. fiscal response is fundamentally altering investment strategies 27 March 2020 — Since the start of 2020, unprecedented economic disruption...